TwinBeech Capital’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
TwinBeech Capital's OCUL Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 106,377 shares worth $816K. The stake represents 0.19% of the portfolio and ranks #154 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in OCUL as recently as Q4 2025.
TwinBeech Capital first reported a position in OCUL in Q2 2021 and has held it in 4 quarters since. The position peaked at $1.7M in Q4 2025. 258 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- TwinBeech Capital held 106,377 shares of Ocular Therapeutix worth $816K as of Q3 2026.
- Ocular Therapeutix was a new TwinBeech Capital position in Q3 2026.
- Ocular Therapeutix made up 0.19% of TwinBeech Capital's portfolio in Q3 2026, its #154 holding.
- TwinBeech Capital first reported a position in Ocular Therapeutix in Q2 2021 and has held it in 4 quarters since.
- TwinBeech Capital's Ocular Therapeutix position peaked at $1.7M in Q4 2025.
- 258 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.